49G-23969-90968
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Moderna
-
2021-04-30
Dose 2 — Moderna
-
2021-12-19
Dose 3 — Pfizer-BioNTech
-
2021-12-20
Registered in v-safe
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-21
- 2021-12-22
- 2021-12-23
- 2021-12-25
- 2021-12-26
- 2022-01-02
- 2022-01-09
- 2022-01-16
- 2022-01-23
- 2022-01-30
- 2022-03-20
- 2022-06-19
-
2022-12-19
Survey response — 12 months, dose 3MedDRA: Influenza like illness — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu like symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Moderna | No |
| 2 | 2021-04-30 | Moderna | No |
| 3 | 2021-12-19 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: Flu like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza like illness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release